ICUI Stock Performance, Insider Transaction and News

ICUI - ICU Medical, Inc.

Market Cap	4.13B	P/E	-	EPS this Y	-31.00%	Ern Qtrly Grth	-
Income	-29.66M	Forward P/E	20.08	EPS next Y	43.30%	50D Avg Chg	-5.00%
Sales	2.26B	PEG	1.33	EPS past 5Y	-4.67%	200D Avg Chg	-
Dividend	N/A	Price/Book	1.96	EPS next 5Y	16.00%	52W High Chg	-19.00%
Recommedations	2.20	Quick Ratio	0.92	Shares Outstanding	24.37M	52W Low Chg	33.00%
Insider Own	12.86%	ROA	0.67%	Shares Float	21.01M	Beta	0.71
Inst Own	89.51%	ROE	-1.41%	Shares Shorted/Prior	0.99M/0.92M	Price	171.50
Gross Margin	32.75%	Profit Margin	-1.31%	Avg. Volume	179,493	Target Price	136.00
Oper. Margin	-0.93%	Earnings Date	May 6	Volume	157,604	Change	-1.83%

Healthcare | Medical Instruments & Supplies | United States

About ICU Medical, Inc.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

ICU Medical, Inc. News

04/12/24	Shareholders in ICU Medical (NASDAQ:ICUI) are in the red if they invested five years ago
03/13/24	ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum
03/05/24	Smiths Medical recalls nearly 86,000 syringe pumps over software problem
03/01/24	ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference
03/01/24	Earnings Update: ICU Medical, Inc. (NASDAQ:ICUI) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
02/28/24	ICU Medical, Inc. (NASDAQ:ICUI) Q4 2023 Earnings Call Transcript
02/28/24	Q4 2023 ICU Medical Inc Earnings Call
02/28/24	Zacks.com featured highlights include ICU Medical and Ardmore Shipping
02/27/24	ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates
02/27/24	ICU Medical Inc (ICUI) Posts Mixed Q4 Results; Provides 2024 Guidance
02/27/24	ICU Medical Announces Fourth Quarter 2023 Results and Provides Fiscal Year 2024 Guidance
02/27/24	2 Stocks in Focus as New Analysts Initiate Coverage
02/20/24	Analysts Estimate ICU Medical (ICUI) to Report a Decline in Earnings: What to Look Out for
02/14/24	Smiths Medical recalls syringe pumps for software malfunction
02/13/24	‘Fundamentals Appear Positive’: KeyBanc Suggests 2 MedTech Stocks With up to ~40% Upside
02/13/24	ICU Medical Announces Time of Fourth Quarter 2023 Earnings Conference Call
11/29/23	Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 50% Discount?
11/27/23	Carlyle Group and WP Carey Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600
11/07/23	ICU Medical, Inc. (NASDAQ:ICUI) Q3 2023 Earnings Call Transcript
11/06/23	ICU Medical Inc (ICUI) Reports Q3 2023 Earnings: Revenue Down 7.5%, Net Income Turns Positive

ICUI Chatroom

KSTom Posted - 1 week ago

$ICUI I like that forcast, as for now, faire price should be $4

Bavcat Posted - 2 weeks ago

$ICUI love this , but dang this gets old

StockInvest_us Posted - 03/29/24

Signal alert: $ICUI - PivotPoint bottom https://stockinvest.us/l/EDdh2LIvwK

YouOnlyLiveTwice Posted - 03/25/24

$ICUI I would short this to $85… Trading @ 20x eps w no growth

CurrentSeaFlow Posted - 03/22/24

$ICU Remember when I asked about $ICUI compared to ICU? Looks like it popped 2 days after we fell -- not sure if that's related or if its just the market. Anyone have any comments?

murahrah Posted - 03/21/24

$ICUI Bad news on this company is priced in. I am not suggesting this is going up anytime soon but the floor has been established. Its time for them to underpromise and overdeliver which they should be able to do

steveboehm Posted - 03/21/24

$ICUI $ICU 7.8 % of the float is short. Hardly heavily shorted but you go ahead and believe that if it makes you feel better

DDolla95 Posted - 03/20/24

$HSCS takes time...$BEAM is on deck for a call today....$cdio $ICUI

YouOnlyLiveTwice Posted - 03/19/24

$ICUI This company is radioactive stay away or wait for 15-20 points lower

iQuicky Posted - 1 month ago

$ICUI ICU I don’t want to go lol

insiderbuyingselling Posted - 1 month ago

$ICUI new insider selling: 7978 shares. http://insiderbuyingselling.com/?t=ICUI

insiderbuyingselling Posted - 1 month ago

$ICUI new insider selling: 1522 shares. http://insiderbuyingselling.com/?t=ICUI

DailyStocksPicks Posted - 1 month ago

Oversold Pick #4: $AGL financial underperformance highlighted by a significant earnings miss for Q4 2023 and downward adjustments in future EPS estimates, alongside analyst downgrades and an underweight rating from Barclays makes it oversold. Despite institutional investors like Wellington Management Group LLP and Morgan Stanley increasing their positions, the stock reached a new 52-week low, reflecting market concerns about the company's growth prospects and profitability challenges. Mixed social media sentiment and concerns over the company's cash burn and operational challenges in the Medicare Advantage sector add to the bearish outlook. These elements, combined with strategic management shifts such as the transition of the Chief Medical Officer and widened revenue guidance for FY24, signal uncertainty and contribute to the perception of the stock being oversold. $PGNY, $SHC, $EVO, $ICUI For More Details: https://youtu.be/Ff3pi-Ew5Og

GoodTidings Posted - 1 month ago

$ICU Take advantage of these gifts... We got a blockbuster product for Pediatric and soon for Adult $23 billion market Sepsis... Buy average down and hold til $100+ and let the dumpers pay for their stupid manipulation!!! This is a longtime investment... We will follow similar path like $ICUI... 😃😃😃💪💪💪💸💸💸

insiderbuyingselling Posted - 1 month ago

$ICUI new insider selling: 3412 shares. http://insiderbuyingselling.com/?t=ICUI

Stock_Titan Posted - 1 month ago

$ICUI ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum https://www.stocktitan.net/news/ICUI/icu-medical-to-present-at-the-key-banc-life-sciences-med-tech-zs02yznc0mp4.html